Israel’s Technion Develops ‘Electronic Nose’ to Detect Cancer
Researchers at Israel’s Technion are developing an "electronic nose” that can "smell” head-and-neck cancer, which is often discovered too late.
Researchers at Israel’s Technion are developing an "electronic nose” that can "smell” head-and-neck cancer, which is often discovered too late.
Israeli hospitals are on the cutting edge of providing treatment for cancer, according to the chief of Oncology at Rambam Medical Center.

Technion researchers have come up with a new and simple blood test that may be able to detect cancer.

A Knesset committee received worrisome data regarding the incidence of cancer in the northern port city.

Tel Aviv Univ develops a molecular "smart bomb" that can lead to more effective and safer chemotherapy for those suffering from the dread disease.
Tel Aviv U researchers developing new medicines that could prevent cancer and make existing cancer a manageable chronic illness.

Tel Aviv U researchers discover that routine blood tests can provide an early warning for colorectal cancer.

Researchers at Tel Aviv Universities are on track to finding a way to stop cancer cells from multiplying and spreading.

Leading international bio-medical experts will be presenting their findings at a conference in Jerusalem, with an eye toward personalized cures.

A group of teens and parents are in Israel - many for the first time–to celebrate recovery from cancer, thanks to Chai Lifeline & Hartman Family.

In a major breakthrough, scientists have found a gene that appears to be responsible for repeated relapses in a severe form of children’s leukemia.

Unique but not conclusive Israeli study indicates Holocaust survivors suffer from cancer more than those who came to Israel before Holocaust.

Israeli pharmaceutical giant Teva has signed a deal to invest $60 million in a new cancer-fighting drug to fight prostate and lung cancer.
A new cancer drug developed by Tel Aviv University researcher has been licensed for exclusive worldwide rights to develop and market the drug.

Scientists at the Technion have created a breath analysis test with an 86 percent success rate in detecting lung cancer.

Top cancer researcher Dr. David Sidransky brings innovative cancer treatment to Israel and believes it will lead in biotechnology as in hi-tech.
